Motor, Sensory, and Autonomic Function in Traumatic Spinal Cord Injury After the LION Procedure.
SCI-LION
1 other identifier
interventional
16
1 country
1
Brief Summary
Possover pioneered a minimally invasive and fully reversible laparoscopic technique, laparoscopic implantation of neuroprosthesis (LION), for precise placement of an implantable pulse generator and one to four leads for stimulating nerves of the lumbosacral plexus. Unexpectedly, Possover in 2014 made the clinical observation that four patients with complete and incomplete chronic traumatic spinal cord injury regained significant motor and sensory function following the LION procedure for bladder and bowel dysfunction. The primary objective of this randomized clinical trial is to investigate whether the LION procedure and the subsequent neurostimulation in individuals with chronic traumatic thoracolumbar spinal cord injury with spastic paraplegia is associated with increased walking capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 24, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 28, 2021
March 1, 2021
3 years
January 24, 2018
September 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement/change in walking capacity
Walking index for spinal cord injury, second revision (WISCI II)
Baseline, 3 mo., 6 mo., 9 mo., 12 mo.
Secondary Outcomes (15)
Change in lean body mass
Baseline, 12 mo.
Change in distal motor latency of motor nerve conduction studies
Baseline, 12 mo.
Change in peak-peak amplitude of motor nerve conduction studies
Baseline, 12 mo.
Change in muscle microarchitecture
Baseline, 12 mo.
Change in muscle motor unit number
Baseline, 12 mo.
- +10 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALAll participant in the intervention group will undergo the LION procedure and subsequent neurostimulation.
Control
ACTIVE COMPARATORAll participants in the control group will be issued with a device for neuromuscular electrical stimulation.
Interventions
Laparoscopic implantation of an impulse generator and four leads for electrical stimulation of femoral and sciatic nerves.
Conventional neuromuscular electrical stimulation via surface electrodes.
Eligibility Criteria
You may qualify if:
- Willing and able to give informed consent for participation in the clinical investigation, and to comply with all requirements of the clinical investigation
- Traumatic SCI with:
- neurological level below T5 and above L2
- American Spinal Injury Association Impairment Grade A or B
- spasticity in one or both lower extremities
- Injury prior at least 12 months prior to enrollment
You may not qualify if:
- Female subject who is pregnant/planning pregnancy during the clinical investigation.
- Previous surgery/procedures interfering with the LION procedure incl. the presence of other implanted medical devices.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subject at risk because of participation in the clinical investigation, or may influence the result of the clinical investigation, or the subject's ability to participate in the clinical investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spinal Cord Injury Centre of Western Denmarklead
- Aarhus University Hospitalcollaborator
- Regionshospitalet Viborg, Skivecollaborator
- University of Southern Denmarkcollaborator
Study Sites (1)
Helge Kasch
Viborg, Central Jutland, 8800, Denmark
Related Publications (1)
Possover M, Abrao HM. Low-frequency antidromic pelvic neuromodulation as a potential enhancer of recovery after spinal cord injury: hypothetical promotion of spinal Renshaw cells and corticovagal plasticity. J Spinal Cord Med. 2025 Sep 15:1-7. doi: 10.1080/10790268.2024.2414146. Online ahead of print.
PMID: 40952735DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Helge Kasch, MD
Spinal Cord Injury Centre of Western Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2018
First Posted
February 22, 2018
Study Start
January 1, 2018
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
September 28, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data may be requested by other researchers. Approvals from the Danish Data Protection Agency and individual participants will be required before data may be shared.